Merck wins a third FDA nod for antibiotic; Mereo tackles TIGIT with $70M raise in hand
→ Merck — one of the last big pharma bastions in the beleaguered field of antibiotic drug development — on Friday said the FDA had signed off …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
